Dec 15 (Reuters) - Shares of French pharmaceutical group Sanofi fell 4% on Monday after it flagged another delay to a U.S.
Dec 15 (Reuters) - Gilead Sciences said on Monday its experimental HIV treatment met the main goal in a late-stage trial. The ...
Charlie Sheen reveals an experimental HIV drug that "never made it to market" and discusses his sobriety journey since 2017 ...
Dec 15 (Reuters) - Immunome said on Monday its experimental drug met the main goal in a late-stage study for patients with a rare type of tumor. The oral drug, varegacestat, is being tested in ...
Ianalumab, a monoclonal antibody, helped patients with immune thrombocytopenia (ITP) maintain safe platelet counts without ...
A next-generation obesity shot from Eli Lilly & Co. helped patients lose almost a quarter of their body weight, potentially ...
5don MSN
Scientists Say This Weight-Loss Drug Is Like ‘Exercise in a Pill’—But What Do Doctors Think?
We asked experts about the buzzy new medication.
Sanofi drug faces FDA delay following a failed late-stage trial for multiple sclerosis, with regulatory guidance expected by Q1 2024.
Shares in argenx fell after the pharmaceutical company said it would stop late-stage trials for an experimental drug to treat thyroid eye disease due to lack of efficacy. In European afternoon trading ...
Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of ...
The weight-loss drug market is booming, with biotech firms racing to secure their place in a lucrative sector currently ...
Change.org on track to receive more experimental drug petitions than ever. April 2, 2014— -- For a growing number of gravely ill patients running out of options, social media has become their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results